Gissmann L - Search Results

1

Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.

Lei J, Osen W, Gardyan A, Hotz-Wagenblatt A, Wei G, Gissmann L, Eichmüller S, Löchelt M. Lei J, et al. Among authors: gissmann l. PLoS One. 2015 Sep 23;10(9):e0138458. doi: 10.1371/journal.pone.0138458. eCollection 2015. PLoS One. 2015. PMID: 26397953 Free PMC article.

2

Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognition.

Samorski R, Gissmann L, Osen W. Samorski R, et al. Among authors: gissmann l. Immunol Lett. 2006 Sep 15;107(1):41-9. doi: 10.1016/j.imlet.2006.07.003. Epub 2006 Aug 4. Immunol Lett. 2006. PMID: 16949679

3

Immunization against human papillomavirus infection and associated neoplasia.

Osen W, Jochmus I, Müller M, Gissmann L. Osen W, et al. Among authors: gissmann l. J Clin Virol. 2000 Oct;19(1-2):75-8. doi: 10.1016/s1386-6532(00)00090-1. J Clin Virol. 2000. PMID: 11091150

4

T cell response to human papillomavirus 16 E7 in mice: comparison of Cr release assay, intracellular IFN-gamma production, ELISPOT and tetramer staining.

Michel N, Ohlschläger P, Osen W, Freyschmidt EJ, Guthöhrlein H, Kaufmann AM, Müller M, Gissmann L. Michel N, et al. Among authors: gissmann l. Intervirology. 2002;45(4-6):290-9. doi: 10.1159/000067923. Intervirology. 2002. PMID: 12566712

5

Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination.

Michel N, Osen W, Gissmann L, Schumacher TN, Zentgraf H, Müller M. Michel N, et al. Among authors: gissmann l. Virology. 2002 Mar 1;294(1):47-59. doi: 10.1006/viro.2001.1321. Virology. 2002. PMID: 11886264 Free article.

6

Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6 mice.

Steinberg T, Ohlschläger P, Sehr P, Osen W, Gissmann L. Steinberg T, et al. Among authors: gissmann l. Vaccine. 2005 Jan 19;23(9):1149-57. doi: 10.1016/j.vaccine.2004.08.027. Vaccine. 2005. PMID: 15629358

7

Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.

Jochmus I, Osen W, Altmann A, Buck G, Hofmann B, Schneider A, Gissmann L, Rammensee HG. Jochmus I, et al. Among authors: gissmann l. J Gen Virol. 1997 Jul;78 ( Pt 7):1689-95. doi: 10.1099/0022-1317-78-7-1689. J Gen Virol. 1997. PMID: 9225046

8

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.

Ohlschläger P, Osen W, Dell K, Faath S, Garcea RL, Jochmus I, Müller M, Pawlita M, Schäfer K, Sehr P, Staib C, Sutter G, Gissmann L. Ohlschläger P, et al. Among authors: gissmann l. J Virol. 2003 Apr;77(8):4635-45. doi: 10.1128/jvi.77.8.4635-4645.2003. J Virol. 2003. PMID: 12663770 Free PMC article.

9

An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.

Ohlschläger P, Pes M, Osen W, Dürst M, Schneider A, Gissmann L, Kaufmann AM. Ohlschläger P, et al. Among authors: gissmann l. Vaccine. 2006 Apr 5;24(15):2880-93. doi: 10.1016/j.vaccine.2005.12.061. Epub 2006 Jan 19. Vaccine. 2006. PMID: 16472545

10

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection.

Schäfer K, Müller M, Faath S, Henn A, Osen W, Zentgraf H, Benner A, Gissmann L, Jochmus I. Schäfer K, et al. Among authors: gissmann l. Int J Cancer. 1999 Jun 11;81(6):881-8. doi: 10.1002/(sici)1097-0215(19990611)81:6<881::aid-ijc8>3.0.co;2-t. Int J Cancer. 1999. PMID: 10362134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters